Back
Akero Therapeutics Quote, Financials, Valuation and Earnings
The #1 free indicator I've used for 30 years
The indicator is free... and the 23-page book I wrote for you is also free.
Sell
40
AKRO
Akero Therapeutics
Last Price:
21.98
Seasonality Move:
56.48%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion SuperprojectAkero Therapeutics Price Quote
$21.98
+0.05 (+-1.79%)
(Updated: July 4, 2024 at 5:38 AM ET)
Akero Therapeutics Key Stats
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Day range:
$21.74 - $22.39
52-week range:
$11.25 - $53.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.79%
Volume:
216.3K
Avg. volume:
935.6K
1-year change:
-50.74%
Market cap:
$1.5B
Revenue:
$0
EPS:
$-3.23
How Much Does Akero Therapeutics Make?
Data Unavailable
Is Akero Therapeutics Growing As A Company?
Data Unavailable
Akero Therapeutics Stock Price Performance
-
Did Akero Therapeutics Stock Go Up Last Month?
Akero Therapeutics share price went up by 14.28% last month -
Did AKRO's Share Price Rise Over The Last Year?
AKRO share price fell by -50.74% over the past 1 year
What Is Akero Therapeutics 52-Week High & Low?
-
What Is Akero Therapeutics’s 52-Week High Share Price?
Akero Therapeutics has traded as high as $53.77 over the past 52 weeks -
What Is Akero Therapeutics’s 52-Week Low Share Price?
Akero Therapeutics has traded as low as $11.25 over the past 52 weeks
Akero Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akero Therapeutics?
-
How Much Debt Does Akero Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Akero Therapeutics Have?
Cash and short term investments quarterly total is $903.7M -
What Is Akero Therapeutics’s Book Value Per Share?
Book value per share is 12.24
Is Akero Therapeutics Cash Flow Positive?
-
What Is AKRO Cash Flow From Operations?
Cash flow from operations (TTM) is -$155.9M -
What Is Akero Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $705.1M -
What Is Akero Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$183.4M
Akero Therapeutics Return On Invested Capital
Data Unavailable
Akero Therapeutics Earnings Date & Stock Price
-
What Is Akero Therapeutics's Stock Price Today?
A single share of AKRO can be purchased today for 21.93 -
What Is Akero Therapeutics’s Stock Symbol?
Akero Therapeutics trades on the nasdaq under the ticker symbol: AKRO -
When Is Akero Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Akero Therapeutics is scheduled on August 9, 2024 -
When Is AKRO's next ex-dividend date?
Akero Therapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Akero Therapeutics Stock?
You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akero Therapeutics Competitors
-
Who Are Akero Therapeutics's Competitors?
Below is a list of companies who compete with Akero Therapeutics or are related in some way:
Akero Therapeutics Dividend Yield
Data Unavailable
Akero Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 2.83% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 44.56 |
| Upside from Last Price: | 103.17% |